prismasol bgk2/3.5

Generic: calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride

Labeler: vantive us healthcare llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name prismasol bgk2/3.5
Generic Name calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride
Labeler vantive us healthcare llc
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

anhydrous dextrose 20 g/L, calcium chloride 5.15 g/L, lactic acid 5.4 g/L, magnesium chloride 2.03 g/L, potassium chloride .157 g/L, sodium bicarbonate 3.09 g/L, sodium chloride 6.46 g/L

Manufacturer
Vantive US Healthcare LLC

Identifiers & Regulatory

Product NDC 24571-103
Product ID 24571-103_37da3e2a-3a1a-1784-e063-6394a90a969f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021703
Listing Expiration 2026-12-31
Marketing Start 2006-10-25

Pharmacologic Class

Classes
acidifying activity [moa] blood coagulation factor [epc] calcium [cs] calculi dissolution agent [epc] cations divalent [cs] increased coagulation factor activity [pe] increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] inhibition small intestine fluid/electrolyte absorption [pe] magnesium ion exchange activity [moa] osmotic activity [moa] osmotic laxative [epc] phosphate binder [epc] phosphate chelating activity [moa] potassium compounds [cs] potassium salt [epc] stimulation large intestine fluid/electrolyte secretion [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24571103
Hyphenated Format 24571-103

Supplemental Identifiers

UNII
M4I0D6VV5M GR686LBA74 660YQ98I10 451W47IQ8X 5SL0G7R0OK 02F3473H9O 8MDF5V39QO 33X04XA5AT

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name prismasol bgk2/3.5 (source: ndc)
Generic Name calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride (source: ndc)
Application Number NDA021703 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 20 g/L
  • 5.15 g/L
  • 5.4 g/L
  • 2.03 g/L
  • .157 g/L
  • 3.09 g/L
  • 6.46 g/L
source: ndc
Packaging
  • 2 BAG in 1 CASE (24571-103-06) / 5 L in 1 BAG
source: ndc

Packages (1)

24571-103-06 2 BAG in 1 CASE (24571-103-06) / 5 L in 1 BAG

Ingredients (7)

anhydrous dextrose (20 g/L) calcium chloride (5.15 g/L) lactic acid (5.4 g/L) magnesium chloride (2.03 g/L) potassium chloride (.157 g/L) sodium bicarbonate (3.09 g/L) sodium chloride (6.46 g/L)

Linked Drug Pages (1)

PRISMASOL BGK2/0, PRISMASOL BGK2/3.5, PRISMASOL BGK4/2.5, PRISMASOL BGK0/2.5, PRISMASOL B22GK4/0, PRISMASOL BK0/0/1.2, PRISMASOL BGK4/0/1.2, PHOXILLUM BK4/2.5, PHOXILLUM B22K4/0 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "37da3e2a-3a1a-1784-e063-6394a90a969f", "openfda": {"unii": ["M4I0D6VV5M", "GR686LBA74", "660YQ98I10", "451W47IQ8X", "5SL0G7R0OK", "02F3473H9O", "8MDF5V39QO", "33X04XA5AT"], "spl_set_id": ["7f675fee-8940-4ece-bb0c-75ac79d8708c"], "manufacturer_name": ["Vantive US Healthcare LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BAG in 1 CASE (24571-103-06)  / 5 L in 1 BAG", "package_ndc": "24571-103-06", "marketing_start_date": "20061025"}], "brand_name": "PRISMASOL BGK2/3.5", "product_id": "24571-103_37da3e2a-3a1a-1784-e063-6394a90a969f", "dosage_form": "INJECTION", "pharm_class": ["Acidifying Activity [MoA]", "Blood Coagulation Factor [EPC]", "Calcium [CS]", "Calculi Dissolution Agent [EPC]", "Cations", "Divalent [CS]", "Increased Coagulation Factor Activity [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Phosphate Binder [EPC]", "Phosphate Chelating Activity [MoA]", "Potassium Compounds [CS]", "Potassium Salt [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "24571-103", "generic_name": "calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride", "labeler_name": "Vantive US Healthcare LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PRISMASOL", "brand_name_suffix": "BGK2/3.5", "active_ingredients": [{"name": "ANHYDROUS DEXTROSE", "strength": "20 g/L"}, {"name": "CALCIUM CHLORIDE", "strength": "5.15 g/L"}, {"name": "LACTIC ACID", "strength": "5.4 g/L"}, {"name": "MAGNESIUM CHLORIDE", "strength": "2.03 g/L"}, {"name": "POTASSIUM CHLORIDE", "strength": ".157 g/L"}, {"name": "SODIUM BICARBONATE", "strength": "3.09 g/L"}, {"name": "SODIUM CHLORIDE", "strength": "6.46 g/L"}], "application_number": "NDA021703", "marketing_category": "NDA", "marketing_start_date": "20061025", "listing_expiration_date": "20261231"}